Meanwhile, some studies have found that CD103+CD8+ TRMs are positively correlated with OS in patients with esophageal squamous carcinoma, which has an effective anti-tumor effect after immune checkpoint blockers (ICBs) and is not affected by chemotherapy [23]. The gene discussed is CD8A; the disease is neoplasm.